Investigation of Naphthyl–Polyamine Conjugates as Antimicrobials and Antibiotic Enhancers
Melissa M. Cadelis,
Liam R. Edmeades,
Dan Chen,
Evangelene S. Gill,
Kyle Fraser,
Florent Rouvier,
Marie-Lise Bourguet-Kondracki,
Jean Michel Brunel,
Brent R. Copp
Affiliations
Melissa M. Cadelis
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
Liam R. Edmeades
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
Dan Chen
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
Evangelene S. Gill
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
Kyle Fraser
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
Florent Rouvier
Membranes et Cibles Thérapeutiques (MCT), SSA, INSERM, Aix-Marseille Universite, 27 bd Jean Moulin, 13385 Marseille, France
Marie-Lise Bourguet-Kondracki
Laboratoire Molécules de Communication et Adaptation des Micro-organismes, UMR 7245 CNRS, Muséum National d’Histoire Naturelle, 57 rue Cuvier (C.P. 54), 75005 Paris, France
Jean Michel Brunel
Membranes et Cibles Thérapeutiques (MCT), SSA, INSERM, Aix-Marseille Universite, 27 bd Jean Moulin, 13385 Marseille, France
Brent R. Copp
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
As part of our search for new antimicrobials and antibiotic enhancers, a series of naphthyl- and biphenyl-substituted polyamine conjugates have been synthesized. The structurally-diverse library of compounds incorporated variation in the capping end groups and in the length of the polyamine (PA) core. Longer chain (PA-3-12-3) variants containing both 1-naphthyl and 2-naphthyl capping groups exhibited more pronounced intrinsic antimicrobial properties against methicillin-resistant Staphylococcus aureus (MRSA) (MIC ≤ 0.29 µM) and the fungus Cryptococcus neoformans (MIC ≤ 0.29 µM). Closer mechanistic study of one of these analogues, 20f, identified it as a bactericide. In contrast to previously reported diarylacyl-substituted polyamines, several examples in the current set were able to enhance the antibiotic action of doxycycline and/or erythromycin towards the Gram-negative bacteria Pseudomonas aeruginosa and Escherichia coli. Two analogues (19a and 20c) were of note, exhibiting greater than 32-fold enhancement in activity. This latter result suggests that α,ω-disubstituted polyamines bearing 1-naphthyl- and 2-naphthyl-capping groups are worthy of further investigation and optimization as non-toxic antibiotic enhancers.